Cargando…
Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells
Ovarian cancer is a primary gynecological malignancy with a global 5-year survival rate of 44%. The majority of patients present with advanced disease at initial diagnosis because of the lack of an effective early detection screening test. Circular RNAs (circRNAs) within exosomes in the circulatory...
Autores principales: | Wang, Xinchen, Yao, Yingyu, Jin, Meiyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732319/ https://www.ncbi.nlm.nih.gov/pubmed/33028742 http://dx.doi.org/10.18632/aging.103706 |
Ejemplares similares
-
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer
por: Ge, Lili, et al.
Publicado: (2022) -
Identification of circ_0000375 and circ_0011536 as novel diagnostic biomarkers of colorectal cancer
por: Yin, Teng-Fei, et al.
Publicado: (2022) -
BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2018) -
CircRNA circ_0072995 promotes the progression of epithelial ovarian cancer by modulating miR-147a/CDK6 axis
por: Ding, Jin, et al.
Publicado: (2020) -
CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review
por: Foruzandeh, Zahra, et al.
Publicado: (2021)